Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-04 Purchase |
2025-02-05 3:17 pm |
Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer |
1,000 | $3.1 | $3,100 | 155,793 (Direct) |
View |
| 2025-02-04 Purchase |
2025-02-04 5:05 pm |
Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer |
1,000 | $2.98 | $2,980 | 154,793 (Direct) |
View |
| 2024-12-20 Purchase |
2025-01-29 5:26 pm |
Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer |
1,000 | $2.75 | $2,750 | 411,793 (Direct) |
View |
| 2025-01-28 Purchase |
2025-01-29 5:22 pm |
Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer |
1,500 | $2.7 | $4,050 | 153,793 (Direct) |
View |
| 2025-01-13 Purchase |
2025-01-24 4:55 pm |
Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer |
3,000 | $2.5667 | $7,700 | 152,293 (Direct) |
View |
| 2024-10-28 Purchase |
2024-10-30 10:55 am |
Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer |
500 | $2.19 | $1,095 | 148,293 (Direct) |
View |
| 2024-08-13 Purchase |
2024-08-15 4:25 pm |
Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer |
1,000 | $0.95 | $950 | 147,793 (Direct) |
View |
| 2024-06-28 Purchase |
2024-07-01 1:47 pm |
Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer |
1,000 | $1.75 | $1,750 | 146,793 (Direct) |
View |
| 2024-06-18 Purchase |
2024-06-21 11:21 am |
Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer |
1,619 | $0.71 | $1,149 | 145,793 (Direct) |
View |
| 2024-06-10 Purchase |
2024-06-12 1:19 pm |
Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer |
3,000 | $0.64 | $1,920 | 144,174 (Direct) |
View |
| 2022-09-16 Purchase |
2022-09-20 2:05 pm |
Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer |
2,500 | $4.15 | $10,375 | 141,174 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-26 Option Award |
2025-02-27 4:33 pm |
2025-02-26 2033-06-30 |
Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer |
919,184 | $0 | 1,853,189 (Direct) |
View |
| 2024-11-07 Ownership |
2025-01-29 5:26 pm |
2024-11-07 2029-08-26 |
Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer |
262,500 | $0 | 411,793 (Direct) |
View |
Ownership |
2022-09-19 5:03 pm |
N/A N/A |
Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer |
0 | $0 | 138,674 (Direct) |
View |